Abbott william r - direct investment history in Cardiogenesis corp ca

Filed on 2011-05-17 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-11-028874.txt Sec File: edgar/data/1213180/0001209191-11-028874-index.htm

2011-05-17 Abbott William R (CIK 1213180) through Direct (Senior Vp Cfo)

Invested in Cardiogenesis Corp Ca sold 175000 shares at $0.327 remaining shares owned 0

Stock Option Right To Buy Cardiogenesis Corp Ca Cgcp.Pk exercise price 0.13 has valueitem expiration due date 2019-02-23 underlying security shares 175000 underlying security title Common Stock

f2 option cancelled pursuant to the merger in exchange for cash consideration equal to the difference between $0.457 and the exercise price of the option multiplied by the number of options canceled. this transaction is exempt under rule 16b-3(e).


Filed on 2011-05-17 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-11-028874.txt Sec File: edgar/data/1213180/0001209191-11-028874-index.htm

2011-05-17 Abbott William R (CIK 1213180) through Direct (Senior Vp Cfo)

Invested in Cardiogenesis Corp Ca sold 100000 shares at $0.157 remaining shares owned 0

Stock Option Right To Buy Cardiogenesis Corp Ca Cgcp.Pk exercise price 0.30 has valueitem expiration due date 2017-01-03 underlying security shares 100000 underlying security title Common Stock

f2 option cancelled pursuant to the merger in exchange for cash consideration equal to the difference between $0.457 and the exercise price of the option multiplied by the number of options canceled. this transaction is exempt under rule 16b-3(e).


Filed on 2011-05-17 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-11-028874.txt Sec File: edgar/data/1213180/0001209191-11-028874-index.htm

2011-05-17 Abbott William R (CIK 1213180) through Direct (Senior Vp Cfo)

Invested in Cardiogenesis Corp Ca sold 100000 shares at $0 remaining shares owned 0

Stock Option Right To Buy Cardiogenesis Corp Ca Cgcp.Pk exercise price 0.49 has valueitem expiration due date 2016-05-15 underlying security shares 100000 underlying security title Common Stock

f2 option cancelled pursuant to the merger in exchange for cash consideration equal to the difference between $0.457 and the exercise price of the option multiplied by the number of options canceled. this transaction is exempt under rule 16b-3(e).


Filed on 2011-05-17 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-11-028874.txt Sec File: edgar/data/1213180/0001209191-11-028874-index.htm

2011-05-17 Abbott William R (CIK 1213180) through Direct (Senior Vp Cfo)

Invested in Cardiogenesis Corp Ca sold 66038 shares remaining shares owned 0

Common Stock Cardiogenesis Corp Ca Cgcp.Pk Transaction code: D Sale (or disposition) back to the issuer of the securities

f1 disposed of pursuant to that certain amended and restated agreement and plan of merger, dated april 14, 2011, by and among cryolife, inc., cl falcon, inc., and cardiogenesis corporation in exchange for cash consideration equal to $0.457 per share on the effective date of the merger (the "merger"). this transaction is exempt under rule 16b-3(e).


Filed on 2010-04-06 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-10-021215.txt Sec File: edgar/data/1213180/0001209191-10-021215-index.htm

2010-03-31 Abbott William R (CIK 1213180) through Direct (Senior Vp Cfo)

Invested in Cardiogenesis Corp Ca sold 10886 shares at $0.38 remaining shares owned 66038

Common Stock Cardiogenesis Corp Ca Cgcp.Pk Transaction code: F Payment of exercise price or tax liability by delivering or withholding securities

f1 33% of a restricted award vested on 3/31/10. a portion of the vested shares were withheld to pay taxes applicable to the vesting.


Filed on 2009-04-01 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-09-019353.txt Sec File: edgar/data/1213180/0001209191-09-019353-index.htm

2009-03-31 Abbott William R (CIK 1213180) through Direct (Sr Vp Cfo)

Invested in Cardiogenesis Corp Ca bought 76924 shares at $0.00 remaining shares owned 76924

Common Stock Cardiogenesis Corp Ca Cgcp.Pk Transaction code: A Grant, award, or other acquisition

f1 represents shares of restricted stock. 33% of the shares shall vest on 3/31/10, 33% of the shares shall vest on 3/31/11 and 34% of the shares shall vest on 3/31/12, subject to the reporting person continuing to be an employee or consultant on such dates.


Filed on 2009-02-25 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-09-011674.txt Sec File: edgar/data/1213180/0001209191-09-011674-index.htm

2009-02-23 Abbott William R (CIK 1213180) through Direct (Sr Vp Cfo)

Invested in Cardiogenesis Corp Ca bought 175000.00 shares at $0 remaining shares owned 175000

Stock Optionright To Buy Cardiogenesis Corp Ca Cgcp.Pk exercise price 0.13 has valueitem expiration due date 2019-02-23 underlying security shares 175000.00 underlying security title Common Stock

f1 shares subject to the option vest at one third on the first anniversary of the grant date with the remaining two thirds vesting on a monthly basis through 02/23/2012


Filed on 2007-01-16 by Abbott William R SEC CIK 1213180 Form 4

Accession 0001209191-07-003635.txt Sec File: edgar/data/1213180/0001209191-07-003635-index.htm

2007-01-03 Abbott William R (CIK 1213180) through Direct (Sr Vp Cfo)

Invested in Cardiogenesis Corp Ca bought 100000 shares at $0.00 remaining shares owned 100000

Stock Option Right To Buy Cardiogenesis Corp Ca Cgcp.Pk exercise price 0.30 has valueitem expiration due date 2017-01-03 underlying security shares 100000 underlying security title Common Stock

f1 shares subject to the option vest at 25% per year on each of the first four anniversary dates of the grant.